At first, we tried to perform correlation analysis between the decreased SRRC and increased SCap with the decreased CML, decreased IL-1α, and increased SOD activity in various blood glucose control subgroups. The gene discussed is IL1A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.